Investors

Insider Transactions

Date Name Title Sorted Ascending Type Shares Traded Price Range
Jul 6, 2009 vagelos p roy Director Disposition (Non Open Market) 11,837 n/a
Jan 5, 2010 vagelos p roy Director Disposition (Non Open Market) 8,595 n/a
Aug 28, 2008 vagelos p roy Director Disposition (Non Open Market) 8,106 n/a
Mar 29, 2008 vagelos p roy Director Disposition (Non Open Market) 10,669 n/a
Jun 13, 2008 vagelos p roy Director Acquisition (Non Open Market) 115,082 n/a
Jun 13, 2008 vagelos p roy Director Disposition (Non Open Market) 115,082 n/a
Jul 9, 2008 vagelos p roy Director Disposition (Non Open Market) 8,105 n/a
Jul 10, 2008 vagelos p roy Director Disposition (Non Open Market) 30,705 n/a
Aug 4, 2008 vagelos p roy Director Disposition (Non Open Market) 114,309 n/a
Aug 4, 2008 vagelos p roy Director Acquisition (Non Open Market) 114,309 n/a
Oct 6, 2008 vagelos p roy Director Disposition (Non Open Market) 9,270 n/a
Dec 8, 2009 vagelos p roy Director Option Execute 187,500 8.77
Dec 19, 2008 vagelos p roy Director Option Execute 130,000 7.41
Feb 27, 2008 vagelos p roy Director Option Execute 6,666 7.91
Sep 6, 2011 aberman michael s Officer Option Execute 8,334 24.00
Sep 2, 2011 aberman michael s Officer Option Execute 4,166 24.00
Dec 17, 2015 aberman michael s Officer Option Execute 4,000 24.00
Feb 23, 2015 aberman michael s Officer Option Execute 7,500 30.63
Mar 17, 2015 aberman michael s Officer Option Execute 11,398 24.00
Feb 13, 2015 aberman michael s Officer Option Execute 7,500 24.00
Showing 401-420 of 1021 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)